Idea Proposed/Formulated by: Dr L Boominathan Ph.D.
Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/
To cite: Boominathan, MiRNA-based therapy for glucose intolerance, insulin resistance, IDDM, and NIDDM: MiRNA-183 increases the insulin-producing cell mass and function via down regulation of its target gene, 14/June/2014, 11.03 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org
Courtesy: When you cite drop us a line at firstname.lastname@example.org
* Research cooperation